Viewing Study NCT06630546



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06630546
Status: COMPLETED
Last Update Posted: None
First Post: 2024-10-04

Brief Title: Trabecular Microbypass IStent in Patients with Glaucoma
Sponsor: None
Organization: None

Study Overview

Official Title: Trabecular Microbypass IStent in Patients with Glaucoma
Status: COMPLETED
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to assess the safety and efficacy of phacoemulsification combined with one trabecular micro-bypass stent implantation phaco-iStent versus phacoemulsification alone in a Taiwanese population as well as to investigate any differences in outcomes between patients with primary open angle glaucoma POAG and those with normal tension glaucoma NTG The main question it aims to answer is

How much do intraocular pressure IOP and the number of antiglaucoma medications change after iStent insertion with subgroup analyses for POAG and NTG Researchers will compare phacoemulsification combined with one trabecular micro-bypass stent implantation phaco-iStent versus phacoemulsification alone to see if IOP and the number of antiglaucoma medications decrease

Participants will receive their regular phacoemulsification and decided whether to receive iStent by themselves
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None